Versigent (VGNT) – What Are Investment Firms Saying About This Stock?

Versigent (NYSE:VGNT) has been given an average rating of “Moderate Buy” by the fourteen brokerages that are presently covering the firm, Marketbeat.com reports. Three analysts have rated the stock with a hold recommendation and eleven have given a buy recommendation to the company. The average 12 month price objective among brokers that have issued ratings on the stock in the last year is $54.00.

Several equities analysts recently weighed in on the stock. TD Cowen raised their price target on shares of Versigent from $49.00 to $58.00 and gave the company a “buy” rating in a research report on Wednesday, August 5th. Weiss Ratings raised shares of Versigent from a “hold (c)” rating to a “hold (c+)” rating in a research report on Thursday, October 8th. Wells Fargo & Company increased their price objective on shares of Versigent from $48.00 to $56.00 and gave the company an “overweight” rating in a research note on Wednesday, August 5th. Zacks Research lowered Versigent from a “strong-buy” rating to a “hold” rating in a report on Wednesday, August 5th. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and set a $54.00 target price on shares of Versigent in a research report on Wednesday, August 5th.

Insiders Place Their Bets

In related news, Director Kevin Clark sold 74,130 shares of the company’s stock in a transaction that occurred on Wednesday, September 9th. The shares were sold at an average price of $45.67, for a total transaction of $3,385,517.10. Following the sale, the director owned 124,849 shares of the company’s stock, valued at approximately $5,701,853.83. This represents a 37.26% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In the last ninety days, insiders have sold 220,000 shares of company stock valued at $10,065,848.

Institutional Trading of Versigent

A number of hedge funds have recently bought and sold shares of VGNT. Allianz Asset Management GmbH bought a new stake in shares of Versigent in the second quarter worth about $20,602,000. HBK Investments L P bought a new stake in Versigent in the second quarter valued at $14,439,000. Steamboat Capital Partners LLC purchased a new position in Versigent during the 2nd quarter valued at $10,385,000. WINTON GROUP Ltd purchased a new position in Versigent during the 2nd quarter valued at $8,397,000. Finally, Nan Shan Life Insurance Co. Ltd. purchased a new stake in shares of Versigent in the 2nd quarter worth about $5,400,000.

Versigent Stock Performance

Shares of NYSE VGNT opened at $42.55 on Friday. Versigent has a 52-week low of $26.34 and a 52-week high of $50.88. The stock has a 50 day moving average price of $46.31. The company has a debt-to-equity ratio of 7.29, a quick ratio of 1.09 and a current ratio of 1.40.

Versigent (NYSE:VGNT) last announced its quarterly earnings data on Tuesday, August 4th. The company reported $1.92 EPS for the quarter, topping the consensus estimate of $1.58 by $0.34. The company had revenue of $2.44 billion for the quarter, compared to analyst estimates of $2.29 billion. On average, analysts predict that Versigent will post 7.23 earnings per share for the current fiscal year.

Versigent Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 18th. Shareholders of record on Friday, September 4th were issued a dividend of $0.13 per share. The ex-dividend date of this dividend was Friday, September 4th. This represents a $0.52 annualized dividend and a yield of 1.2%.

About Versigent

Versigent PLC is involved in the design, manufacturing and delivery of low and high voltage power electrical architectures. Versigent PLC is based in SCHAFFHAUSEN, Switzerland.